Xenetix

Xenetix (Iobitridol) is an iodinated contrast agent used in medical imaging procedures like CT scans. It enhances visibility of internal structures for diagnostic purposes. This non-ionic, low-osmolality agent is administered intravenously. Suitable for patients requiring contrast-enhanced imaging.

Iobitridol is primarily used as a contrast medium in computed tomography (CT) scans to improve the visibility of blood vessels, organs, and tissues. It helps radiologists identify abnormalities such as tumors, blockages, or inflammation. This agent is also employed in other imaging techniques where contrast enhancement is required, including angiography and urography. Patients undergoing these procedures may benefit from its use to achieve clearer diagnostic images.

After intravenous administration, Iobitridol circulates through the bloodstream and enhances the contrast of internal structures during imaging. Patients may notice a warm sensation or metallic taste temporarily during injection. These effects are generally mild and short-lived. Some individuals may experience a brief feeling of flushing or nausea, which typically resolves quickly.

Iobitridol should only be administered by healthcare professionals trained in contrast media use. Patients with a history of severe allergic reactions, kidney disease, or thyroid disorders should inform their healthcare provider before use. Adequate hydration is recommended before and after administration to support kidney function. Pregnant or breastfeeding individuals should consult their doctor prior to use.

Certain medications, such as metformin or nephrotoxic drugs, may interact with Iobitridol and require careful monitoring. Alcohol use around the time of administration may increase the risk of side effects. Patients taking diuretics or other medications affecting kidney function should discuss potential risks with their healthcare provider. Always disclose all current medications to the administering physician.